InnoCare Pharma Goes Back to Funding Trough With STAR Market Listing
The Hong Kong-traded company will become the latest from the cash-challenged pharma sector to make a second listing on the A-share market Key Takeaways: InnoCare Pharma’s A-share IPO will make…
RELATED ARTICLES
-
Debt pressures cast cloud over Fosun Pharma results
2196.HK 600196.SHG
-
FAST NEWS: InnoCare inches closer to profitability on strong sales gains
9969.HK
-
FAST NEWS: InnoCare’s loss narrows on higher lymphoma drug sales
9969.HK
-
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK 6185.HK
-
BeiGene goes for global growth with sales and R&D push
BGNE.US 6160.HK
-
Henlius finds elixir in first profits, scraps A-share IPO
2696.HK
-
BeiGene still bleeding red ink despite blockbuster drug
BGNE.US 6160.HK 688235.SHG
Discover hidden China stock gems in our weekly newsletter